The widespread application of lung transplantation is limited by the shortage of suitable
donor organs resulting in longer waiting times for listed patients with a substantial risk of …

An international conference of transplant physicians, surgeons, and allied health
professionals was held in Vancouver, Canada, on September 15 and 16, 2005 to address …

These long-time barriers to widespread use of living organ donation, and the resulting
desire of transplant professionals to ensure that undesirable risks to donors are minimized …

Risk–benefit assessment is a routine requirement for research ethics committees that review
and oversee biomedical research with human subjects. Nevertheless, it remains unclear …

The 2007 American Society of Transplant Surgeons'(ASTS) State-of-the-Art Winter
Symposium entitled,'Solving the Organ Shortage Crisis' explored ways to increase the …

Living lobar lung transplantation places two donors at risk for each recipient. We examined
the perioperative outcomes associated with the 253 donor lobectomies performed at our …

Although lung transplantation is a well-accepted treatment for advanced lung diseases,
donor shortage remains a significant limiting factor resulting in an increasing number of …

BACKGROUND: Living-donor lobar lung transplantation was developed as an alternative to
cadaveric transplantation. However, whether two pulmonary lobes provide comparable …

Living donor lobar lung transplantation (LDLLT) was developed in order to mitigate the
growing competition for deceased donor (DD) lungs and resultant increase in waiting list …

Living lobar lung transplantation was developed as a procedure for adult and pediatric
patients considered too ill to await cadaveric transplantation. One hundred thirty-eight living …